Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Cerus" found in our extensive corporate database of over 50,000 company records.
At Cerus Corporation we have developed a platform technology (Helinx®) that prevents nucleic acid (DNA and RNA) replication. The Company's initial application of this technology is the development of the INTERCEPT Blood Systems to inactivate viruses, bacteria and other pathogens in the blood components used for transfusion - platelets, plasma and red blood cells.
Condensed Consolidated Unaudited Balance Sheets